Acute necrotizing encephalopathy
| Necrotizing encephalopathy | |
|---|---|
| Other names | Acute necrotizing encephalitis, Acute necrotizing encephalopathy of childhood (ANEC), infection-induced acute encephalopathy (IIAE), Autosomal dominant acute necrotising encephalopathy (ADANE), Acute Hemorrhagic Necrotizing Encephalopathy |
| Specialty | Infectious disease Neurology. |
| Symptoms | fever, cough, congestion, vomiting and diarrhea, for several days. After these flu-like symptoms, the affected individuals develop neurological problems, such as seizures, hallucinations, difficulty coordinating movements (ataxia) or abnormal muscle tone.[1] |
| Causes | Influenza is the most common virus found in people with acute necrotizing encephalopathy type 1; other viruses that are known to trigger this condition include human herpesvirus 6, coxsackie virus, and enteroviruses. In rare cases, the bacterium Mycoplasma pneumoniae is involved.[1] |
| Prevention | Vaccination,[2] face coverings, quarantine, physical/social distancing, ventilation, hand washing[3] |
| Medication | Steroid and intravenous immunoglobulin (IVIG) |
| Prognosis | Approximately one-third of individuals with acute necrotizing encephalopathy type 1 do not survive their illness and subsequent neurological decline. Of those who do survive, about half have permanent brain damage due to tissue necrosis, resulting in impairments in walking, speech, and other basic functions, there may also be permanent brain damage.[1] |
| Frequency | At least 59 cases of this condition have been reported in the scientific literature[1] |
Acute necrotizing encephalopathy (ANE) or sometimes necrotizing encephalitis or infection-induced acute encephalopathy (IIAE) is a rare type of brain disease (encephalopathy) that occurs following a viral infection.[4] Most commonly, it develops secondary to infection with influenza A, influenza B, and the human herpes virus 6. ANE can be familial or sporadic, but both forms are very similar to each other. Multiple subtypes, associated with specific genes have been found.[5]
Symptoms and signs
[edit]Acute necrotizing encephalopathy typically appears in infancy or early childhood, although some people do not develop the condition until adolescence or adulthood. People with this condition usually show typical symptoms of an infection, such as fever, cough, congestion, vomiting, and diarrhea, for a few days. Following these flu-like symptoms, affected individuals develop neurological problems, such as seizures, hallucinations, difficulty coordinating movements (ataxia), or abnormal muscle tone. Eventually, most affected individuals go into a coma, which usually lasts for a number of weeks. The condition is described as "acute" because the episodes of illness are time-limited.[1]
People with acute necrotizing encephalopathy develop areas of damages (lesions) in certain regions of the brain. As the condition progresses, these brain regions develop swelling (edema), bleeding (hemorrhage), and then tissue death (necrosis). The progressive brain damage and tissue loss results in encephalopathy.[1]
Genetics
[edit]ANE can be familial or sporadic, but both forms are very similar to each other. Most familial cases are caused by genetic changes in the RANBP2 gene, and are known as infection-induced acute encephalopathy 3 (IIAE3) or acute necrotizing encephalopathy type 1 (ANE1).[5]
In addition there is acute infection-induced (herpes-specific) encephalopathy-1 (IIAE1) associated with a homozygous UNC93B1 gene; and herpes-specific IIAE2 associated with the TLR3 gene;[6] as well as IIAE4, associated with the CPT2 gene;[7] herpes-specific IIAE5 associated with the TRAF3 gene;[8] herpes-specific IIAE6 associated with the TICAM1 gene;[9] herpes-specific IIAE7 associated with the IRF3 gene;[10] herpes-specific IIAE8 associated with the TBK1 gene;[11] IIAE9 associated with the NUP214 gene;[12] herpes-specific IIAE10 associated with the SNORA31 gene;[13] and herpes-specific IIAE11 associated with the DBR1 gene.[14]
Diagnosis
[edit]![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section is empty. You can help by adding to it. (May 2024) |
Treatment
[edit]Optimal treatment regimes for the condition are not known. Suggested treatments may be corticosteroids and cytokine regulators such as TNF inhibitors.[4][1]
Prognosis
[edit]Approximately one-third of individuals with acute necrotizing encephalopathy do not survive their illness and subsequent neurological decline. Of those who do survive, about half have permanent brain damage due to tissue necrosis, resulting in impairments in walking, speech, and other basic functions. Over time, many of these skills may be regained, but the loss of brain tissue is permanent. Other individuals who survive their illness appear to recover completely.[1]
It is estimated that half of individuals with acute necrotizing encephalopathy are susceptible to recurrent episodes and will have another infection that results in neurological decline; some people may have numerous episodes throughout their lives. Neurological function worsens following each episode as more brain tissue is damaged.[1]
History
[edit]The first case in the medical literature was described in 1955 by Belgian neurologist Ludo van Bogaert.[15]
References
[edit]- ^ a b c d e f g h i "Acute necrotizing encephalopathy type 1". MedlinePlus. United States National Library of Medicine. Retrieved June 27, 2022.
This article incorporates text from this source, which is in the public domain.
- ^ "COVID-19 vaccines". World Health Organization (WHO). Retrieved 3 March 2021.
- ^ Talic, S; Shah, S; Wild, H; Gasevic, D; Maharaj, A; Ademi, Z; Li, X; Xu, W; Mesa-Eguiagaray, I; Rostron, J; Theodoratou, E (17 November 2021). "Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis". BMJ (Clinical Research Ed.). 375: e068302. doi:10.1136/bmj-2021-068302. ISSN 1756-1833. PMC 9423125. PMID 34789505. S2CID 244271780.
- ^ a b "Acute necrotizing encephalopathy - National Organization for Rare Disorders". rarediseases.org. 2022-06-16. Retrieved 2023-03-05.
- ^ a b "Acute necrotizing encephalopathy - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2023-03-05.
- ^ "Entry - *603029 - TOLL-LIKE RECEPTOR 3 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #614212 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #614849 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #614850 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6; IIAE6 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #616532 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #617900 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #618426 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #619396 - ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 10; IIAE10 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ "Entry - #619441 - ENCEPHALITIS, ACUTE, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, 11; IIAE11 - OMIM". omim.org. Retrieved 2023-03-05.
- ^ Van Bogaert, L.; Radermecker, J.; Devos, J. (1955). "[A fatal case of acute necrosing encephalitis; its position with reference to the group of encephalites transmitted by arthropods and to herpetic encephalitis]". Revue Neurologique. 92 (5): 329–356. ISSN 0035-3787. PMID 13281224.
